Document is current

Article History

Received: 5 April 2021

Accepted: 24 August 2021

First Online: 22 October 2021

Declarations

:

: MDS and WMT are inventors on multiple issued and pending patents related to the disclosed technology. These patents are assigned to their primary employer: Canadian Blood Services (Ottawa, ON, Canada). Canadian Blood Services is a not-for-profit organization whose primary mission since its organization in 1998 is to collect, manufacture and manage blood and blood products for all of Canada (except Quebec). Canadian Blood Services is funded solely by the federal, provincial and territorial governments of Canada.

: All human experiments (i.e., blood donations) were reviewed and approved by the University of British Columbia Clinical Research Ethics Board (H02-70215) and done in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki). All murine studies were done in accordance with the Canadian Council of Animal Care and approved by the University of British Columbia Animal Care Committee (A17-0220) and were conducted within the Centre for Disease Modeling at the University of British Columbia.

: Informed consent was obtained from all donors prior to blood collection.

: All authors have read and approved the paper. If the paper is accepted, all authors will observe the terms of the license to publish.